Beta

    fda approve mdma for ptsd

    Before Jan 1, 2032

    fda approve mdma for ptsd. Best Yes near 59¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 59¢ · Best No: 48¢ · 1 platform

    • Kalshi: Yes 59¢ / No 48¢
    LIVE

    Before Jan 1, 2032

    Volume

    $69

    $0 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jan 1, 2032

    ~2025 days left

    Category

    Culture

    59¢CHANCE OF YES55%45%
    Yes
    59¢
    Kalshi
    No
    48¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    KalshiKalshi
    Best Yes
    Best No
    Yes
    59¢
    No
    48¢
    Vol
    $69
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2032, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 59¢: exit costs ~1.69¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jan 1, 2032
    Time Left2025 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In